Exhibit 99.2

Dr. Reddy’s Laboratories Ltd. 8-2-337, Road No. 3, Banjara Hills, Hyderabad - 500 034, Telangana,
India. CIN : L85195TG1984PLC004507       Tel      : +91 40 4900 2900 Fax     : +91 40 4900 2999 Email : mail@drreddys.com www.drreddys.com

September 10, 2022

National Stock Exchange of India Ltd. (Scrip Code: DRREDDY-EQ)

BSE Limited (Scrip Code: 500124)

Dear Sirs,

Sub: Intimation under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Schedule of Analyst / Institutional Investor Meetings

This is to inform you that the Company’s management will be participating in the following investor conferences for group and one-on-one meetings:

Date	Conference	Location
13th September, 2022	Morgan Stanley 20th Annual Global Healthcare Conference	New York, USA
13th September, 2022	29th Annual CITIC CLSA Flagship Investors’ Forum 2022	Virtual
16th September, 2022	BofA Global Research Global Healthcare Conference 2022	London, UK
20th September, 2022	J.P. Morgan India Investor Summit 2022	New Delhi, India

Please note that the schedule of the aforesaid meetings is subject to change due to any exigencies on the part of investors / Company.

This is for your information.

Thanking you.

Yours faithfully,

For Dr. Reddy’s Laboratories Limited

/s/ K Randhir Singh

K Randhir Singh

Company Secretary & Compliance Officer

CC:-	New York Stock Exchange Inc.(Stock Code :RDY)
	NSE IFSC Ltd